Membership
Tour
Register
Log in
Saumya Roy
Follow
Person
Bangalore, IN
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Substituted bicyclic compounds useful as T cell activators
Patent number
11,964,973
Issue date
Apr 23, 2024
Bristol-Myers Squibb Company
Robert G. Gentles
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
Patent number
11,713,316
Issue date
Aug 1, 2023
Bristol-Myers Squibb Company
Upender Velaparthi
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Substituted pyridopyrimidinonyl compounds useful as T cell activators
Patent number
11,584,747
Issue date
Feb 21, 2023
Upender Velaparthi
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Patent number
11,253,525
Issue date
Feb 22, 2022
Bristol-Myers Squibb Company
James Aaron Balog
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
Patent number
10,959,986
Issue date
Mar 30, 2021
Bristol-Myers Squibb Company
James Aaron Balog
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
Patent number
10,954,238
Issue date
Mar 23, 2021
Bristol-Myers Squibb Company
Upender Velaparthi
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
Patent number
10,669,272
Issue date
Jun 2, 2020
Bristol-Myers Squibb Company
Upender Velaparthi
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
Patent number
10,399,932
Issue date
Sep 3, 2019
Bristol-Myers Squibb Company
James Aaron Balog
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
Patent number
10,399,933
Issue date
Sep 3, 2019
Bristol-Myers Squibb Company
James Aaron Balog
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
IDO inhibitors
Patent number
10,167,254
Issue date
Jan 1, 2019
Bristol-Myers Squibb Company
James Aaron Balog
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
IDO inhibitors
Patent number
9,790,169
Issue date
Oct 17, 2017
Bristol-Myers Squibb Company
James Aaron Balog
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR
Publication number
20240108654
Publication date
Apr 4, 2024
Juno Therapeutics, Inc.
David G. KUGLER
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
Publication number
20230151007
Publication date
May 18, 2023
Bristol-Myers Squibb Company
Upender Velaparthi
C07 - ORGANIC CHEMISTRY
Information
Patent Application
COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS
Publication number
20230089255
Publication date
Mar 23, 2023
Bristol-Myers Squibb Company
Susan WEE
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
Publication number
20220324859
Publication date
Oct 13, 2022
Bristol-Myers Squibb Company
Upender VELAPARTHI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
Publication number
20210355113
Publication date
Nov 18, 2021
Bristol-Myers Squibb Company
James Aaron BALOG
C07 - ORGANIC CHEMISTRY
Information
Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
Publication number
20210299126
Publication date
Sep 30, 2021
Bristol-Myers Squibb Company
James Aaron BALOG
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS
Publication number
20210188845
Publication date
Jun 24, 2021
Bristol-Myers Squibb Company
Robert G. Gentles
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
Publication number
20210061802
Publication date
Mar 4, 2021
Bristol-Myers Squibb Company
Upender Velaparthi
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
Publication number
20200109140
Publication date
Apr 9, 2020
Bristol-Myers Squibb Company
Upender VELAPARTHI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
Publication number
20200069646
Publication date
Mar 5, 2020
Bristol-Myers Squibb Company
James Aaron Balog
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
Publication number
20200069695
Publication date
Mar 5, 2020
Bristol-Myers Squibb Company
James Aaron Balog
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
Publication number
20180079712
Publication date
Mar 22, 2018
Bristol-Myers Squibb Company
James Aaron Balog
C07 - ORGANIC CHEMISTRY
Information
Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
Publication number
20180072660
Publication date
Mar 15, 2018
Bristol-Myers Squibb Company
James Aaron Balog
C07 - ORGANIC CHEMISTRY
Information
Patent Application
IDO INHIBITORS
Publication number
20170231999
Publication date
Aug 17, 2017
Bristol-Myers Squibb Company
James Aaron Balog
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
IDO INHIBITORS
Publication number
20160289171
Publication date
Oct 6, 2016
Bristol-Myers Squibb Company
James Aaron Balog
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE